Fredrik Alpsten

Chair & Board Member – Audit Committee

Fredrik Alpsten (b. 1966). Chairman since 2025.
Nationality: Swedish

Education/Background: B.Sc. in Business and Economics from the Stockholm School of Economics. Former CEO of Devyser Diagnostics AB, CEO of US-based Clinical Diagnostic Solutions Inc, CFO of Boule Diagnostics AB, CFO of IRRAS AB, CFO at Algipharma AB, and CEO and CFO of Doxa AB.  He has also been chairman of Personlig Almanacka Nordic AB, board member at Binero Group AB, and board member at Pharmetheus AB.

Current roles: Chair of Prolight Diagnostics, Board Member of Squid (Njuice AB), and an alternate board member of Fredrik Alpsten Consulting AB.

Holding: 0 shares.

Independent of the company, its management, and major shareholders.